Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms (2022)
Source: Cancers. Unidades: ICB, FM
Subjects: FARMACOLOGIA, LEUCEMIA, ANTINEOPLÁSICOS, MICROTÚBULOS, LEUCÓCITOS, GLICOPROTEÍNAS
ABNT
VICARI, Hugo Passos et al. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, v. 14, n. 24, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14246080. Acesso em: 02 nov. 2024.APA
Vicari, H. P., Lima, K. C. de, Costa-Lotufo, L. V., & Machado Neto, J. A. (2022). Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, 14( 24), 1-15. doi:10.3390/cancers14246080NLM
Vicari HP, Lima KC de, Costa-Lotufo LV, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/cancers14246080Vancouver
Vicari HP, Lima KC de, Costa-Lotufo LV, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/cancers14246080